Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D N, Benslay"'
Publikováno v:
Annals of the New York Academy of Sciences. 99:30-44
Publikováno v:
Agents and Actions. 34:100-102
LY221068, 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxy phenyl]methylene]-3-(dimethylamino)-4-thiazolidinone, and the monomethylamino analog, LY269415, are anti-oxidants and potent inhibitors of iron dependent lipid peroxidation and 5-lipoxygenase enzyme.
Publikováno v:
Annals of the New York Academy of Sciences. 696:415-416
Autor:
A M, Bendele, K J, Ruterbories, S M, Spaethe, D N, Benslay, T D, Lindstrom, S J, Lee, R W, Naismith
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 260(3)
BF389 (Biofor 389) is a potent anti-inflammatory agent in various animal models including adjuvant and type II collagen arthritis in rats. In vitro assays indicate that this compound is a mixed inhibitor of arachidonic acid metabolism. The compound w
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 259(1)
Pergolide, a dopamine agonist effective in the treatment of Parkinson's disease, has been shown to have anti-inflammatory activity in the carrageenan paw edema assay in rats at p.o. doses greater than or equal to 0.3 mg/kg. Studies were done to inves
Autor:
D. N. Benslay, Alison M. Bendele
Publikováno v:
Agents and actions. 34(1-2)
Polyarthritis can be induced in rats using a synthetic adjuvant, N,N-dioctyldecyl-N', N-bis(2-hydroxyethyl) propanediamine (LA) suspended in oil. The disease is morphologically indistinguishable from the classic adjuvant arthritis induced by Freund's
Autor:
R. Nickander, D. N. Benslay
Publikováno v:
Agents and actions. 12(3)
Benoxaprofen, a new nonsteroidal anti-inflammatory agent recently marketed as an an antirheumatic drug, has been reported to suppress leucocyte migration into inflammatory sites, possibly by its reported inhibition of leukotriene synthesis. Benoxapro
Autor:
D N, Benslay, R, Nickander
Publikováno v:
European journal of rheumatology and inflammation. 5(2)
The ability of benoxaprofen to suppress bone damage associated with adjuvant-induced arthritis in rats was studied radiographically over a 49-day period. Benoxaprofen was administered orally at a daily dose of 30 mg/kg. Treated and control groups of
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 188(2)
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 169(1)